IP Library Granted Patent US 9,696,317
Granted Patent B2
US 9,696,317 · App. 14/352,610 · Granted Jul 4, 2017

Greener process to synthesize water-soluble Mn

Inventors: Haw Yang (Princeton Junction, NJ); Chih-Hao Hsia (Plainsboro, NJ)
Assignee: The Trustees of Princeton University
G01N33/588B82Y30/00C01B19/002C09K11/02C09K11/562C09K11/565C09K11/883H01L33/06C01P2002/89C01P2004/04C01P2004/64G01N21/6408Y10T428/2991
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,696,317
App. No.
14/352,610
Granted
Jul 4, 2017
Kind
B2
Abstract

Novel Mn 2+ -doped quantum dots are provided. These Mn 2+ -doped quantum dots exhibit excellent temperature sensitivity in both organic solvents and water-based solutions. Methods of preparing the Mn 2+ -doped quantum dots are provided. The Mn 2+ -doped quantum dots may be prepared via a stepwise procedure using air-stable and inexpensive chemicals. The use of air-stable chemicals can significantly reduce the cost of synthesis, chemical storage, and the risk associated with handling flammable chemicals. Methods of temperature sensing using Mn 2+ -doped quantum dots are provided. The stepwise procedure provides the ability to tune the temperature-sensing properties to satisfy specific needs for temperature sensing applications. Water solubility may be achieved by passivating the Mn 2+ -doped quantum dots, allowing the Mn 2+ -doped quantum dots to probe the fluctuations of local temperature in biological environments.

Claims (27)

1. An Mn 2+ -doped quantum dot comprising:

a fluorescent semiconductor core comprising CdSSe;

an initial shell covering the fluorescent semiconductor core, wherein the initial shell is an initial ZnS shell, an initial CdS shell, or an initial ZnSe shell;

an Mn 2+ dopant associated with the initial shell; and

a protection shell covering the initial shell and the Mn 2+ dopant, wherein the protection shell is a ZnSe protection shell or a Zn 1-x Cd x S protection shell, wherein X is the ratio of Cd/(Cd+Zn) in the Zn 1-x Cd x S protection shell and has a value from 0 to 0.5.

2. The Mn 2+ -doped quantum dot of claim 1 further comprising a passivating agent associated with the protection shell.

3. The Mn 2+ -doped quantum dot of claim 2 , wherein the passivating agent is D-penicillamine.

4. The Mn 2+ -doped quantum dot of claim 2 , wherein the passivating agent is cystine.

5. The Mn 2+ -doped quantum dot of claim 2 , wherein the passivating agent is selected from the group consisting of dihydrolipoic acid, dihydrolipoic acid derivatives, a polyethylene glycol functionalized dihydrolipoic acid, and an —SH group functionalized passivating agent.

6. A method of labeling a biological specimen comprising:

contacting the biological specimen with the Mn 2+ -doped quantum dot of claim 1 .

7. The method of claim 6 , wherein the biological specimen is a tissue, a cell, an intracellular organelle, an individual protein or a cellular component.

8. An Mn 2+ -doped quantum dot comprising:

A fluorescent semiconductor core comprising a substance selected from the group consisting of copper indium sulfide, zinc indium copper sulfide, indium phosphide, and CdSSe;

an initial shell covering the fluorescent semiconductor core, wherein the initial shell is an initial ZnS shell, an initial CdS shell, or an initial ZnSe shell;

an Mn 2+ dopant associated with the initial shell;

a protective shell covering the initial shell and the Mn 2+ dopant, wherein the productive shell is a ZnSe protective shell or a Zn 1-x Cd x S protective shell where X is the ratio of Cd/(Cd+Zn) in the Zn 1-x Cd x S protective shell and has a value from 0 to 0.5 and

a passivating agent associated with the protective shell selected from D-penicillamine or cysteine.

9. The Mn 2+ -doped quantum dot of claim 8 , wherein the fluorescent semiconductor core includes CdSSe.

10. The Mn 2+ -doped quantum dot of claim 8 , wherein the passivating agent is D-penicillamine.

11. The Mn 2+ -doped quantum dot of claim 8 , wherein the passivating agent is cystine.

12. The Mn 2+ -doped quantum dot of claim 8 , wherein the protection shell is a ZnS protection shell, which is the Zn 1-x Cd x S protection shell when x is zero.

13. The Mn 2+ -doped quantum dot of claim 8 , wherein the protection shell is the ZnSe protection shell.

14. The Mn 2+ -doped quantum dot of claim 8 , wherein the protection shell is the Zn 1-x Cd x S protection shell.

15. The Mn 2+ -doped quantum dot of claim 1 , wherein the protection shell is a ZnS protection shell, which is the Zn 1-x Cd x S protection shell when x is zero.

16. The Mn 2+ -doped quantum dot of claim 1 , wherein the protection shell is the ZnSe protection shell.

17. The Mn 2+ -doped quantum dot of claim 1 , wherein the protection shell is the Zn 1-x Cd x S protection shell.

Assignments (1)
CONFIRMATORY LICENSE Recorded Jul 17, 2015
From: PRINCETON UNIVERSITY
To: ENERGY, UNITED STATES DEPARTMENT OF
Reel/Frame 036131/0460 →
Continuity (2)
Provisional Application 61548486 · Oct 18, 2011
Related Publication 20140242631A1 · Aug 28, 2014